Bookmark and Share

Array (ARRY) To Present At The Annual J.P. Morgan Healthcare Conference

BOULDER, Colo., Dec. 27, 2012 /PRNewswire/ — Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Annual J.P. Morgan Healthcare Conference in San Francisco.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.

(Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)

Event:

Annual J.P. Morgan Healthcare Conference

Presenter:

Ron Squarer, Chief Executive Officer, Array BioPharma

Date:

Tuesday, January 8, 2013

Time:

3:00 p.m. Pacific Time

Location:

Westin St. Francis Hotel, San Francisco

Webcast:

www.arraybiopharma.com

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small-molecule drugs to treat patients afflicted with cancer. Array is evolving into a late-stage development company, with two wholly-owned programs, ARRY-614 and ARRY-520, and three partnered programs, selumetinib (with AstraZeneca), MEK162 (with Novartis), and danoprevir (with InterMune / Roche), having the potential to begin Phase 3 or pivotal trials by the end of calendar year 2013.  For more information on Array, please go to www.arraybiopharma.com.

CONTACT:

Tricia Haugeto

Array BioPharma Inc.

303-386-1193

thaugeto@arraybiopharma.com

Thursday, December 27th, 2012 Uncategorized
Top Small Cap Market News